Sean P. Nolan - 16 Aug 2023 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Chief Executive Officer, Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
16 Aug 2023
Net transactions value
+$400,000
Form type
4
Filing time
16 Aug 2023, 20:52:21 UTC
Previous filing
18 May 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $400,000 +444,444 +41% $0.9000 1,535,545 16 Aug 2023 See Footnote F1
holding TSHA Common Stock 1,170 16 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.